In a recent development in India, the government has announced new guidelines for Covid-19 vaccination for the age group of 18-44 years. The new guidelines allow states and private hospitals to procure vaccines directly from manufacturers. This move comes as a significant step towards ramping up the vaccination drive in the country. The decision to decentralize the vaccine procurement process is aimed at ensuring a more efficient and quick distribution of vaccines to the public. Under the new guidelines, states have been given the flexibility to negotiate prices with vaccine manufacturers, which is expected to bring down the cost of vaccines and make them more accessible to the general public. Additionally, the government has also decided to provide advance payment to vaccine manufacturers to boost production and ensure an uninterrupted supply of vaccines. This decision is expected to address the issues of vaccine shortage and help in achieving the target of vaccinating a significant portion of the population by the end of the year. The move has been welcomed by experts and healthcare professionals who believe that decentralizing the vaccine procurement process will help in speeding up the vaccination drive and controlling the spread of the virus. With the new guidelines in place, it is expected that more people will have access to vaccines and the vaccination process will become more streamlined and efficient. The government has urged states and private hospitals to take advantage of the new guidelines and expedite the vaccination process to protect the population from the deadly virus. The success of the vaccination drive is crucial in controlling the spread of Covid-19 and returning to normalcy.